Trial Profile
Phase II Randomized Comparison Clinical Trial of Target Activated CIK for Advanced Gastric Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Anti-CD3/MUC1-armed cytokine induced killer cells-Benhealth Biopharmaceutical (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 24 May 2020 Planned primary completion date changed from 5 Apr 2020 to 20 May 2020.
- 10 Sep 2019 Planned primary completion date changed from 5 Apr 2019 to 5 Apr 2020.
- 20 Jun 2018 New trial record